ASP Isotopes (NASDAQ:ASPI) COO Robert Ainscow Sells 8,438 Shares of Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 8,438 shares of ASP Isotopes stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $7.00, for a total value of $59,066.00. Following the transaction, the chief operating officer owned 2,281,879 shares in the company, valued at $15,973,153. This trade represents a 0.37% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Thursday, April 16th, Robert Ainscow sold 22,500 shares of ASP Isotopes stock. The shares were sold at an average price of $5.21, for a total value of $117,225.00.

ASP Isotopes Trading Down 8.6%

NASDAQ:ASPI opened at $5.85 on Thursday. ASP Isotopes Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $14.49. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.39 and a quick ratio of 4.37. The stock has a market capitalization of $736.52 million, a PE ratio of -2.81 and a beta of 3.42. The business’s 50-day simple moving average is $5.65 and its 200-day simple moving average is $5.84.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.06. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.The business had revenue of $8.36 million for the quarter, compared to analysts’ expectations of $3.68 million.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Encompass Capital Advisors LLC acquired a new position in shares of ASP Isotopes during the first quarter worth about $30,551,000. Alyeska Investment Group L.P. boosted its position in shares of ASP Isotopes by 73.4% during the fourth quarter. Alyeska Investment Group L.P. now owns 4,895,546 shares of the company’s stock worth $26,191,000 after buying an additional 2,072,851 shares during the period. Vanguard Group Inc. raised its holdings in ASP Isotopes by 37.9% during the third quarter. Vanguard Group Inc. now owns 4,516,763 shares of the company’s stock worth $43,451,000 after acquiring an additional 1,241,024 shares in the last quarter. Rovida Investment Management Ltd raised its holdings in ASP Isotopes by 28.1% during the fourth quarter. Rovida Investment Management Ltd now owns 4,100,000 shares of the company’s stock worth $21,894,000 after acquiring an additional 900,000 shares in the last quarter. Finally, UBS Group AG raised its holdings in ASP Isotopes by 150.3% during the fourth quarter. UBS Group AG now owns 2,406,457 shares of the company’s stock worth $12,875,000 after acquiring an additional 1,445,165 shares in the last quarter. 16.80% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have recently weighed in on ASPI shares. Canaccord Genuity Group reaffirmed a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, ASP Isotopes presently has a consensus rating of “Hold” and an average target price of $13.00.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.